GMP Pharmaceuticals offers a one-stop shop for small New Zealand health supplement developers wanting their product manufactured, packed, exported and even launched.
GMP Pharmaceuticals is a fast-growing force in the health-conscious Asian market, supplying supplements and functional foods with valued New Zealand origins.
Auckland-based GMP is the biggest contract manufacturer of supplements in New Zealand, employing 165 people and providing spin-off employment for smaller companies. It has specialised in supporting small New Zealand nutritionals suppliers to enter potentially lucrative overseas markets.
GMP general manager Minesh Patel says: “We decided to help the small people develop their ideas, manufacture them, and help them to become big brands in China and Korea”.
The company exports to 20 countries, including Australia, China and Korea.
Patel says the company’s success has grown through its determination to provide a “one stop shop” to people wanting to retail natural supplements.
GMP offers research and development, manufacture and distribution and through intimate involvement with clients’ businesses is also able to advise them on aspects such as initial concepts, packaging, and distribution. For customers wishing to access the Chinese market, it also provides product registration, bonded warehousing facilities, product showcase and launch within facilities set aside for Australasian products.
GMP contract manufactures a number of market ready and customised health supplements. When GMP started exporting in 2004, it had 2,000m2 of factory space. It now has 8,000m2, including an infant formula plant with a capacity of 12 million cans a year. It is anticipated the infant formula market could generate $80 million for GMP in the next three years.
Products are mostly sold to wholesalers and distributors overseas, who in turn supply supermarket chains, healthfood stores, and high-end pharmacies. Indirect sales are achieved in part by using New Zealand migrants with connections in Asia who can set up a profitable business exporting health products from New Zealand.
Revenue in 2011 was $29 million, of which $23 million was earned overseas.